Strikingly, for the patient cohorts and cancer types selected, high CD274 expression appeared to be beneficial for breast cancer (Figure 1A), melanoma (Figure 1B), and renal cancer (Figure 1C) patients. The gene discussed is CD274; the disease is melanoma.